This case describes the process of acquiring Adisseo of France in 2006 by Bluestar Group, the largest subsidiary of ChemChina (a Fortune 500 company). Adisseo was mainly engaged in production of methionine, a feed additive, while China had no methionine production and had relied on its import for a long time. Bluestar started to communicate with Adisseo to acquire the latter's technology in 2000, when Adisseo was not interested. The global burst of bird flu in 2004 provided Bluestar a historical opportunity to purchase Adisseo. Afterward, with the help of intermediate agencies in the fields of strategy, accounting, legal affairs, etc., Bluestar reached an agreement with CVC, Adisseo's parent company, on Oct. 20, 2005, to purchase the whole Adisseo with 400m. The transaction was completed on Jan. 17, 2006. Ren Jianxin, President of Bluestar, was very excited by the largest M&A of a French company by a Chinese company in history. Next, he needed to think about how to complete the integration of adisseo and make it develop well.

【書誌情報】

ページ数：11ページ

サイズ：A4

商品番号：HBSP-TU0070

発行日：2014/11/30

登録日：2015/2/5